Rationale-Adult human cardiomyocytes (CMs) do not complete cytokinesis despite passing through the S-phase of the cell cycle. As a result polyploidization and multinucleation occur. In order to get a deeper understanding of the mechanisms surrounding division of CMs there is a crucial need for a technique to isolate CMs that complete cell division/cytokinesis.
Abstract
Rationale-Adult human cardiomyocytes (CMs) do not complete cytokinesis despite passing through the S-phase of the cell cycle. As a result polyploidization and multinucleation occur. In order to get a deeper understanding of the mechanisms surrounding division of CMs there is a crucial need for a technique to isolate CMs that complete cell division/cytokinesis.
Objective-Markers of cell cycle progression based on DNA content cannot distinguish between mitotic CMs that fail to complete cytokinesis from those cells that undergo true cell division. With the use of molecular beacons (MB) targeting specific mRNAs we aimed to identify truly proliferative CMs derived from hiPSCs.
Methods and Results-Fluorescence activated cell-sorting combined with molecular beacons was performed to sort CM populations enriched for mitotic cells. Expressions of cell-cycle specific genes were confirmed by means of RT-qPCR, single-cell RNA sequencing (scRNA-seq). We further characterized the sorted groups by proliferation assays and time-lapse microscopy which confirmed the proliferative advantage of MB-positive cell populations relative to MB-negative and G2/M populations. Gene expression analysis revealed that the MB-positive CM subpopulation exhibited patterns consistent with the biological processes of nuclear division, chromosome segregation, and transition from M to G1 phase. The use of dual-MBs targeting CDC20 and SPG20 mRNAs (CDC20 + SPG20 + ) enabled the enrichment of cytokinetic events. Interestingly, cells that did not complete cytokinesis and remained binucleated were found to be CDC20 -
SPG20
+ while polyploid CMs that replicated DNA but failed to complete karyokinesis were found to be CDC20
Introduction
Myocardial infarction (MI) remains one of the leading causes of death in the United States and in most industrialized nations throughout the world. 1 In-hospital mortality rates of patients suffering an MI have improved as a result of major advances in cardiovascular science and medicine. 2 However, survivors of MI have an increased risk of developing heart failure and have high rates of early post-discharge death and re-hospitalization. [3] [4] [5] While mortality from coronary artery disease has declined, heart failure has emerged as a leading public health burden worldwide. 4, 6 Ischemia associated cardiomyopathy following a myocardial event is characterized by CM loss and failure of myocardial regeneration. While we have demonstrated that the post-natal human heart retains a modest proliferative potential, 7, 8 the endogenous proliferative capacity of the adult heart remains insufficient for recovery of this CM loss.
It is well known that a majority of postnatal human CMs undergo repeated rounds of DNA replication without cytokinesis resulting in polyploidy and multinucleation. 7, [9] [10] [11] As the human heart matures, the endogenous proliferative capacity diminishes and nonproductive cell cycle activities lead to the formation of binucleated and polyploid daughter cells. The percentage of diploid CMs decreases steadily with a concomitant rise in polyploid cells, with some cells reaching 8N or higher. While this underscores the fact that CMs have substantial capacity for DNA replication, 9 ,12 a unique experimental challenge exists with respect to identifying CMs that complete cytokinesis. Due to their propensity for polyploidization and multinucleation, markers of cell cycle progression based on DNA content such as Ki67 or thymidine analogues cannot distinguish between merely polyploid CMs and those cells that are in the process of true cellular division. Moreover, assays based solely on DNA content do not reveal information on cell stage within M phase of the cell cycle (Fig. 1a,b) . Since DNA content alone does not identify CMs expressing late mitotic markers, novel experimental strategies for identification, sorting, and enrichment of these proliferating cells are required.
Based on quantification of 14 C incorporation into myocardial DNA, we have previously demonstrated that the annual CM turnover rate decreases from 1-2% per year at the age of 25 to 0.45% per year at the age of 75. 7,8 Due to this turnover, approximately 40% of CMs in individuals at 70 years of age have been generated post-birth. 7 Furthermore, we recently reported that these new CMs are derived from pre-existing cytokinetic CMs. 13, 14 A promising strategy to achieve recovery after MI would be enhancement of this endogenous proliferative potential retained by the myocardium. To better understand how to unlock this process, we must first have methods to identify and isolate live proliferating CMs.
Molecular beacons (MBs) allow for RNA detection in live cells. MBs are single-stranded oligonucleotides possessing a stem-loop structure. The loop contains a probe sequence that is complementary to a target sequence, while the stem structure is composed of complementary base pairs that bring a fluorophore and quencher into close proximity. In the presence of a complementary target sequence, the beacon undergoes a conformational change restoring fluorescence. [15] [16] [17] It has been demonstrated that MBs can be used in flow cytometry (FC) assays to identify cells expressing specific mRNA transcripts within a mixed cell population without disrupting gene expression 18 and this approach has been used previously to identify CM subtypes in other contexts. [19] [20] [21] [22] As this strategy allows sorting of live cells, cells may then be used for downstream studies or clinical applications. In this study, we employ human iPSC-derived CMs which are the best current in vitro model of CM cell biology. While these cells in many ways resemble fetal-like CMs, we also tested our hypotheses in cells aged out to increasing levels of maturity, and cross reference our findings with a rat-CM binucleation model.
The cell-division cycle protein 20 (CDC20) is required to activate the anaphase promoting complex initiating chromatid separation and entrance into anaphase, leading to Securin and Cyclin B degradation and eventually mitotic exit.
23-26 Therefore we hypothesized that the level of CDC20 mRNA in live cells would be a candidate marker to indicate cell cycle status of cells in late mitosis. Likewise, the Microtubule Interacting and Trafficking molecule domain-associated gene, SPG20, is associated with the Endosomal Sorting Complexes Required for Transport (ESCRT) machinery and cytokinesis. The SPG20 gene encodes the protein spartin which is involved in the ESCRT pathway and midbody abscission during completion of cell division. [27] [28] [29] Here we investigate to what extent these markers-individually or together-can be targeted with MB technology to enrich cells undergoing anaphase and telophase.
Methods

An expanded Methods section is available in the Online Data Supplement
Differentiation and long-term maintenance of hiPSC-CMs
Episomal human iPSCs 30, 31 (Thermo Fisher Scientific) were maintained as a monolayer on Matrigel (Corning Life Sciences) coated plates and supplemented with RPMI 1640 (Gibco) containing B27 minus insulin (RPMI/B27 -insulin) with GSK3 inhibitor CHIR990216 at D0-1 to induce mesoderm, followed with cardiac differentiation at D4-5 by changing media to RPMI 1640/B27 (-insulin) with Wnt inhibitor IWR1. 31 For long-term hiPSC-CM maintenance, cells were treated with RPMI 1640 (-L-glutamine and -glucose) (Biological Industries USA, Inc.) containing B27 with insulin (RPMI/B27 +insulin) at D10-13. At D13, cells were returned to RPMI/B27 +insulin and stabilized for 48h. Cells were then dissociated and replated onto a new Matrigel-coated well. Media was replaced with fresh RPMI/B27 +insulin every three days.
Isolation of target cells using flow based on MB signal
For MBs complementary to human-specific CDC20 or SPG20 mRNAs, multiple candidate target sequences were designed for each target gene and tested for fluorescence shift prior to cell sorting for cellular amplification of mRNA targets. Probes with the highest fluorescence were considered to pass the flow QC (quality control) and subjected to the RT-qPCR checkpoint. In order to facilitate cellular delivery, all MBs were modified with the cell-penetrating peptide MPG (GALFLGFLGAAGSTMGAWSQPKSKRKV, with N-terminal acetylation and C-terminal cysteamide modification) to form a stable non-covalent complex and promote the uniform and rapid delivery of MBs into cells without interfering with specific targets or hybridization-induced fluorescence. 32, 33 Cells were then added to the MB/MPG complex medium for MB-target hybridization and analyzed/sorted on a BD Influx (BD Biosciences) flow cytometer.
Generation of single cell GEMs and sequencing libraries
After sorting, downstream cDNA synthesis and library preparation were carried out as instructed by the manufacturer 34 (Chromium Single Cell 3' Library & Gel Bead Kit v2). Libraries were standardized for cDNA mass, pooled, and sequenced on an Illumina NextSeq 500 sequencer. 
Bioinformatics analysis of scRNA-seq
Demultiplexed samples were aligned to the reference human genome (version GRCh38) and converted to transcript counts using the Cell Ranger pipeline. The AUCell algorithm 35 was used to perform gene set enrichment analysis. Differences between groups with respect to the AUCell scores were evaluated by t-test. We used the pagoda2 package 36 to identify genes that were differentially expressed between cell populations. Enrichment for gene ontology terms was calculated with the DOSE package.
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Results
MB-MPG delivery and selection of optimal MBs for isolating hiPSC-CMs at M-phase
To differentiate cells in anaphase/telophase from those in earlier stages of mitosis, MBs targeting CDC20 mRNAs were designed to identify mitotic events where the onset of anaphase was likely to occur. CDC20 acts as a key activator promoting metaphase to anaphase transition by converging on the SAC, 26 ,38,39 and we hypothesized that truly proliferative (as opposed to polyploid and binucleated) CMs could be identified based on expression of mRNA encoding markers of late mitosis (CDC20 and SPG20). To accomplish this, we first optimized MB-MPG delivery by evaluating the cell viability, MB background due to endogenous nuclease degradation, and the delivery efficiency by using a positive control MB lacking its quencher ( Fig. 2b ; Online Table 1 ). The MPG sequence used in this study has a variant characterized by a single mutation of the second residue in the nuclear localization sequences (NLS) motif, from lysine to serine (KSKRKV instead of KKKRKV). This mutation has previously been reported to dramatically reduce the import of NLS-containing proteins into the nucleus. 33, 40, 41 As shown in Fig. 2d , the transduction efficiency of ~90% was achieved after 1h incubation with MB-MPG, while maintaining >90% viability. The closely packed contour suggested that the signal shift was due to the cellular uptake of fluorescently labeled MBs (Fig. 2b) . Within the established timeframe, we demonstrated that the MB-MPG delivery was completed without appreciable signal resulting from beacon degradation (Fig 2b,d) . The intracellular uptake efficiency was also tested by incubating MB-MPG with a monolayer of hiPSC-CMs. Fluorescence was detectable in 100% of the live cells 1h after delivery. Homogeneous distribution of fluorescence in both cytoplasm and nucleus was observed, indicating that MPG is a reliable tool for the delivery of mRNA-targeting MBs (Fig. 2c) . We then transduced heterogeneous populations of hiPSC-CMs with MB candidate sequences targeting CDC20 or SPG20 mRNAs to further verify the specificity. The cells were separated by FC based on signal shifts (Fig. 3a, 6b) . Interestingly, G2/M phase cells clearly showed a higher MB signal shift than cells in G1 phase, which was a further indication that the expression of the target sequences was putatively more abundant in the later phase of cell cycle. Two CDC20 MBs passed the flow QC as both MBs resulted in a substantially high percentage of fluorescent cells, and the sorted cells were further characterized by RT-qPCR to check the MB specificity ( Fig. 3a,b; Online Fig. 1b) . In addition to the upregulation of genes involved in cell cycle progression and mitosis, the RT-qPCR analyses also revealed high levels of midbody-associated SPG20 and SPAST (spastin) mRNA expression in sorted CDC20
+ events compared with CDC20 -events (Fig. 3a,b) . The same QC strategies were applied to SPG20 MBs ( Fig. 6b; Online Fig. 1a,b) . Based on qRT-PCR results, CDC20-642 and SPG20-2264 MBs were chosen for further experiments described in this report.
Accounting for non-biologic loss of CTY fluorescence
To quantitate the proliferation advantage of G2/M-CDC20 + CMs relative to G2/M-CDC20 -and G1-CDC20 -CMs, we analyzed sorted populations at different post-sort time points to obtain a time course of CTY fluorescence. We found that more than 30% of cells sorted from G1 had a decrease in fluorescence between 0 and 1h (data not shown), which is unlikely a result of cell cycle progression. In addition, we found no increase in cell count from the G1 sorted population. To quantify the passive efflux of CTY, cells were arrested at G2/M with Nocodazole. In the presence of Nocodazole, cells were plated and harvested at 1h and 2h in order to observe fluorescence. Arrested cells had large decreases in fluorescence at both 1 and 2h (Online Fig.  2b) . Therefore, loss of fluorescence was attributed to a cell specific mechanism other than halving at each division. Since we were confident that G1 cells were not dividing within 18 hours post-sort, we calculated percent dividing cells from G2/M-CDC20 + and G2/M-CDC20 -by subtracting G1 percentage at the same time points.
G2/M-CDC20 + hiPSC-CMs have a proliferative advantage
To further evaluate whether G2/M-CDC20 + CMs were enriched for cells in M phase, we isolated them from D8 cultures and compared gene signatures, cellular morphology, cell counts, and proliferation to the G1, G2/M, and G2/M-CDC20 -cell populations. RT-qPCR analyses of 50 cells showed that G2/M-CDC20 + populations have a selected gene set enriched (p < 0.05, t-test) for cells actively progressing through the cell cycle and are in the late stages of M phase, including CDC20 and SPG20 expression (Fig. 3b) .
In animal cells, the cleavage furrow is formed in late mitosis with the appearance of a shallow groove on the surface of dividing cells. 42 Cultures of G2/M-CDC20 + cells, 1h post-sort, had a significantly higher percentage of cells (16.3±1.55) with a prominent cleavage furrow than G1 (0), G2/M (0), and G2/M-CDC20 -(4.76±5.01) cells (Fig. 3c,d ), suggesting that CDC20 + cells are closer to completion of cell division. Not only was there a significant difference in cleavage furrow formation but the number of cells in the G2/M-CDC20 + population were higher. Based on cell counting of live cells at 1h post-sort, G2/M-CDC20 + cells were about 1.6x more numerous vs G1 and G2/M cells and about 1.3x more numerous than the G2/M-CDC20 -cell population which also had observed cleavage furrow formation (Fig. 3e) .
Flow cytometry and live cell imaging confirmed the significant differences evident at 1h in overnight tracking of cellular proliferation. We used an intracellular dye (CTY) to quantify cell division by FC. With each cell division, the dye concentration dilutes due to sharing the intracellular components with daughter cells and the subsequent synthesis of new cytoplasmic components. To control for loss of signal due to intrinsic effects (described above), we normalized the fluorescence intensity observed in the G2/M populations (both CDC20 -and CDC20 + ) to that observed in the G1 phase. Decrease of fluorescence signal was observed in nearly the entirety of the G2/M-CDC20 + population indicating that these cells had undergone at least one cell division (Fig 4a) . In contrast, progression through mitosis in the G2/M-CDC20 -population took longer, and not all these cells completed cell division during our window of observation. G2/M-CDC20 + cells had an increased percentage of dividing cells at 1, 2, 4, 6, and 18h post sort when compared to G2/M-CDC20 -with the greatest increase in percent divided at 2h (24.9±4.20) vs. (13.3±5.37) (p < 0.05, t-test) (Fig. 4b) . As expected, the percentage of dividing cells declined over time as the pool of parent cells made the switch from M to G1.
G2/M-CDC20
+ cells had increased percentage of cells with a cleavage furrow, cell numbers, and percentage of divided cells, therefore we expected confluency to increase over time. To complement the cell division measurements by FC, we quantified proliferation by cell confluence over time in cultures of each population of interest using live cell imaging. The G2/M-CDC20 + cells exhibited increasing confluence over the 18h incubation (Fig. 4c) while the confluency of the G2/M-CDC20 -cell population was essentially flat. The decrease in G1 confluency over time suggests that cell loss was occurring in these wells and there was neither sufficient time nor pools of cells in late M phase capable of masking the cell loss. With this in mind the change in confluency in G2/M-CDC20 + cultures, and to a lesser extent G2/M-CDC20 -, was even more profound suggesting that there was enough cell division to overcome decreases in viability. The difference in slope between the regression lines was highly significant (p < 0.001).
Single-cell RNA-seq data revealed the significance of enrichment for late-mitosis CMs using MBs
To complement the functional validity for the selection of cytokinetic cells as detailed above we decided to evaluate the cells by a mechanistic approach analyzing the gene expression pattern. From the cells that were sorted by the CM surface marker SIRPA. 43 Cells of CM lineage were identified by expression of TMEM88 44 and/or TNNT2, thereby including CMs from both progenitor and more mature stages. The most immediate feature revealed by tSNE was a gene expression continuum for each sorted event, which correlated with cell cycle progressions (Online Fig. 3 ). Unsupervised clustering of these cells revealed significant overlap of G2/M-CDC20 + and G2/M-CDC20 -cells when clustered by genome wide expression patterns. This finding highlighted the importance of further analysis to clarify any differences between these cells in terms of cell cycle progression, as well as to identify additional markers distinguishing truly mitotic CMs.
Having sorted G2/M-CDC20 -and G2/M-CDC20 + subpopulations based on MB signal, we next examined whether the CDC20 + population was enriched for cells with gene expression patterns consistent with late mitosis. We performed scRNA-seq of cells from three populations (G1-CDC20 -, G2/M-CDC20 -, G2/M-CDC20 + ). We quantified the enrichment of cell cycle stage specific gene sets 45, 46 using a published algorithm tailored to scRNA-seq. 35 Both the G2/M populations (CDC20 + and CDC20 -) showed significant enrichment of the G2/M and M gene signature relative to the G1 population (Fig. 5a) . Intriguingly, the CDC20 + population showed a significant shift in enrichment of the M/G1 gene signature, suggesting these cells were transitioning out of mitosis.
To glean additional functional insight from the gene expression patterns in these cells, we identified those genes that were most consistently and strongly upregulated in the G1/M-CDC20 + cells relative to the other populations (Online Table 3 ; Online Fig. 4) . We then performed Gene Ontology 47, 48 enrichment analysis 37 of the most differentially expressed genes to investigate the indicated cellular role (Fig. 5d) . We queried the entirety of the Gene Ontology Biological Process ontology and without exception the most enriched terms were related to nuclear division, spindle organization, and chromosome segregation (Fig. 5b) . The majority of these upregulated terms specifically related to separation of the sister chromatids, whereas the downregulated differentially expressed genes were significantly enriched in DNA replication (Fig. 5c) . Previous genetic and molecular studies [49] [50] [51] [52] have identified conserved components of the molecular machinery required to achieve cytokinesis. Our AUCell analysis of our scRNA-seq data sets revealed that this core cytokinesis gene set is enriched within G2/M-CDC20 + cells relative to the G2/M-CDC20 -population (Fig. 5e) .
For the dual CDC20/SPG20 MB enrichment strategy, AUCell analysis was conducted using the same gene signatures reflecting five phases of the cell cycle as previously characterized. 45, 46 Although there was no difference in mean AUC Score for the M.G1 signature between CDC20 + SPG20 -and CDC20 + SPG20 + cell populations, the SPG20 + population had a smaller standard deviation (p < 0.0001 F-test) which suggested that the CDC20 + SPG20
+ was a more homogenous population (Fig. 6f) . Based on the genes associated with the completion of cytokinesis, 49 AUCell analysis showed that the CDC20 + SPG20 + events have a more active signature compared to other sorted events (p = 0.004, Fig. 6g ).
Temporal distribution of DNA dye for identification of cell-cycle stage after dual MB-based FC sorting
We investigated whether our CDC20 enrichment strategy enhanced the percentage of cytokinetic events when combined with MBs targeting SPG20 mRNAs. Since our cell model of D8 progenitor/committed hiPSC-CMs was unlikely to have multinucleated cells, 53 quantification of anaphase/telophase events would provide evidence of cytokinesis. G2/M-CDC20
, and G2/M-CDC20 + SPG20 + cell populations were individually sorted into 96-well plates and observed by confocal microscopy ( Online Fig. 5 ). All four phases of mitosis, pro-, meta-, ana-, and telophase were observed (Fig. 6c) . Microscopic observation at high magnification (100X) clearly indicated that cells undergoing karyokinesis were enriched in both G2/M-CDC20 + populations with the difference more pronounced in G2/M-CDC20 + SPG20 + cells (Fig. 6a,c,d; Online Fig. 5 ). The number of late mitotic events increased by threefold in cells sorted based on CDC20 MB (58.9±6.8) and four fold among cells sorted based on CDC20/SPG20 MBs (86.1±10.8) compared to G2/M positive MB negative cells (17.0±2.0) (Fig.  6d) . This demonstrates that that our flow cytometric strategy of additionally targeting SPG20 improved our ability to isolate hiPSC-CMs undergoing cytokinesis.
Distinguishing CM division from polyploidy and binucleation
Polyploidy and multinucleation are characteristic features of mammalian CMs. Multinucleation occurs in the last step of cell division as cytokinesis ceases. One proposed reason for cytokinesis failure during CM binucleation is a defective contractile ring. [54] [55] [56] [57] The contractile actomyosin ring is formed during CM binucleation, which constricts the central spindle resulting in midbody formation. [57] [58] [59] While SPG20 plays a role in midbody abscission, 28 we tested whether our dual-MB strategy was capable of distinguishing cell divisions from binucleated events. P3 rat-CMs were treated with serum and an increase in the percentage of binucleated CMs was observed (Fig. 7a-b) . On D3, ~67±6% of CMs were binucleated (Fig. 7b) . Following serum stimulation, we found that both late-M phase genes Spg20 and Spast were upregulated. Interestingly, Cdc20 was down-regulated (Fig. 7c) . Due to the crucial role of CDC20 at the mitotic checkpoint, the downregulation of Cdc20 was expected among the binucleated events. It seems reasonable to conclude that while SPG20 expression may be involved in binucleation (Fig. 7d) , CDC20 serves as a checkpoint for cytokinesis and can distinguish cytokinetic from acytokinetic (polyploid/multinucleated) events.
To test the hypothesis that the expression levels of SPG20 and CDC20 could identify polyploid and binucleated events in the human system, we returned to hiPSC-CMs at late-stage differentiation. D100 hiPSC-CMs developed polyploidy and binucleation, resembling in vivo human CMs (Fig. 8a,b) . D100 post in vitro differentiation, ~24±4% of CMs were binucleated and ~16±1% of CMs were calculated as poly(tetra)-ploid (Fig. 8b) . We sorted G2/M cells in D100 cultures and checked the gene expressions of CDC20, SPG20, and SPAST. Compared to G2/M phase cells at D8 (Fig. 3a) , the degree of CDC20-MB signal shift was completely absent (Fig. 8c) . RT-qPCR results suggested that CDC20 downregulation at D100 may be associated with the lack of cytokinesis (Fig. 8d) . The lack of SPG20 or SPAST differential expression at the late stage may be explained by the heterogeneous populations mixed with mononucleated (polyploid) and binucleated events. Additional analyses are required to understand the role of SPG20 during polyploidization and binucleation. Initial sorting using our dual-MB strategy on late-stage hiPSC-CMs offers a promising option for the enrichment of binucleated (CDC20 (Fig. 8d) .
Discussion
Postnatally, CMs respond to the increased hemodynamic burden with an increase in cardiac mass through hypertrophy rather than hyperplasia. 9, 27, 60, 61 While hypertrophy is advantageous in terms of maintaining contractility and conserving metabolic resources, 62, 63 proliferative potential is compromised and prevents full recovery from injury. Following injury, interstitial fibrosis and hypertrophy occur together with permanent loss of CMs, leading to pathological remodeling, dysfunction and heart failure. 64, 65 In this study we aim to enhance our ability to study the regulation of CM proliferation towards the future goal of increasing myocardial regeneration following injury.
Since the initial reports of cardiomyocyte renewal in the adult human heart, 7,8 the source of these new cells has remained debated. Ample evidence has been accumulated that new CMs arise from pre-existing CMs rather than adult cardiac stem cells. 13, 66 CM shape and cytoplasmic contents complicate matters-mature and functionally active CMs are elongated and are filled with mitochondria and filaments of the contractile apparatus. This has led investigators to conclude that CMs are most-likely terminally differentiated and incapable of cellular division. Nevertheless, mitosis of CMs has been observed and it has been established that differentiated/contracting CMs complete cytokinesis. This completion of cytokinesis is precluded by the disassembly of the contractile apparatus. 67, 68 With CMs requiring disassembly of their contractile apparatus to undergo mitosis the process of cell division has to be strictly regulated. The molecular events that mediate CM mitotic exit are poorly understood and in order to elucidate the underlying mechanisms resulting in activation of the endogenous cardiac regeneration process, a method for identifying CMs with true proliferative potential is needed. Careful studies of the molecular biology of these cells will be necessary to develop new pharmacological strategies to promote regeneration in the injured myocardium.
Here, we report a high throughput method for separating cytokinetic CMs from polyploidization or binucleation events. Through a combination of FC, gene expression, time-lapse microscopy, and nuclear morphology, we demonstrated that a MB based approach targeting CDC20 and/or SPG20 identified a proliferative subset of CMs derived from hiPSC cells. To verify cell activities and stages we used gene sets previously defined to characterize sorted events. 34, 45, 49, 69 Gene set analyses confirmed MB positive cells to be in late-stages of cytokinesis, including an expression pattern exit to G1 from M.
CMs derived from hiPSCs contract in culture, proliferate early in differentiation and transition into CMs with binucleated and polyploid nuclei later in differentiation. Therefore, hiPSC-CMs are a representative model system with similar cell cycle progression resembling in vivo CMs. hiPSC-CMs early in differentiation resemble fetal or immature CMs 70 and long-term culturing yields hiPSC-CMs that closely resemble adult CMs. 53 Molecular profiling comparing cytokinetic and acytokinetic CMs at sequential stages of hiPSC-CMs during cardiac differentiation will provide a more comprehensive understanding of the mechanisms of cytokinetic CMs. 53 Here, we show that hiPSC-CMs transition from cytokinetic to acytokinetic as differentiation progressed from D8 to D100 (Fig. 8) .
Compared to transgenic systems and fate-mapping experiments to monitor and quantify cytokinesis, [71] [72] [73] [74] our approach provides a versatile means for live intracellular labeling and sorting of cytokinetic CMs without genetic perturbations. The use of our methodology opens the way to investigate downstream use and study in in vivo applications. In contrast to indirect assays such as EdU, Ki-67, pHH3, or Aurora B-kinase which are limited to identifying DNAsynthesis or mitosis without cytokinesis, 75,76 the approach described here identifies CMs that are destined to complete cytokinesis and divide.
Our data suggests that binucleation with the lack of sustained CDC20 expression appears to halt CMs at the binucleated stage. Further delineation of the continuous cell cycle trajectory and the uncoupling of cytokinesis from karyokinesis require a systematic molecular classification at the transcriptome level. The scRNA-seq approach has revolutionized the possibilities for defining distinct cellular states and diversity, [77] [78] [79] thus further exploration of temporal changes in gene expression during mitosis could elucidate the transition from proliferation to a terminally differentiated binucleated phenotype.
In conclusion, we report a MB-based method to identify cytokinetic CMs derived from hiPSCCMs via fluorescence-activated cell sorting based on CDC20 or SPG20 mRNA expressions. This study demonstrates a novel alternative to existing techniques dependent upon DNA content. Our methodology improves current strategies for identification of truly mitotic CMs by circumventing the unique challenges of cells that become polyploid or binucleated due to cytokinesis failure. Our technique will allow for further characterization of proliferative CMs and allow elucidation of the underlying mechanisms responsible for activating endogenous cardiomyocyte renewal, thereby opening the way to development of new therapeutic strategies for patients with myocardial injury. 
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